Posted by Michael Wonder on 26 May 2022
TGA approves new medicine for patients with Cushing's syndrome
26 May 2022 - Osilodrostat phosphate is a cortisol synthesis inhibitor.
The TGA has approved osilodrostat phosphate (Isturisa) for the treatment of endogenous Cushing’s syndrome in adults.
